R3HDM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.741600E-01
Normal-vs-Stage2
1.946440E-01
Normal-vs-Stage3
3.409600E-02
Normal-vs-Stage4
3.494000E-01
Stage1-vs-Stage2
5.580200E-01
Stage1-vs-Stage3
2.832400E-02
Stage1-vs-Stage4
7.406000E-01
Stage2-vs-Stage3
4.536400E-02
Stage2-vs-Stage4
8.899000E-01
Stage3-vs-Stage4
1.068040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.919600E-01
Normal-vs-AfricanAmerican
1.466950E-01
Normal-vs-Asian
3.094400E-01
Caucasian-vs-AfricanAmerican
1.802150E-03
Caucasian-vs-Asian
7.832000E-01
AfricanAmerican-vs-Asian
2.608000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.371600E-01
Normal-vs-Female
1.918160E-01
Male-vs-Female
1.417410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.643200E-01
Normal-vs-Age(41-60Yrs)
6.540600E-01
Normal-vs-Age(61-80Yrs)
1.320570E-01
Normal-vs-Age(81-100Yrs)
1.322600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.483200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.258800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.639600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.602700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.377030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.103000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.920000E-02
Normal-vs-Daily Drinker
5.663200E-01
Normal-vs-Weekly Drinker
8.900300E-02
Normal-vs-Occasional Drinker
5.602200E-01
Normal-vs-Social Drinker
5.147800E-01
Non Drinker-vs-Daily Drinker
7.100100E-02
Non Drinker-vs-Weekly Drinker
9.241200E-01
Non Drinker-vs-Occasional Drinker
7.462300E-03
Non Drinker-vs-Social Drinker
3.688000E-01
Daily Drinker-vs-Weekly Drinker
1.314760E-01
Daily Drinker-vs-Occasional Drinker
7.253400E-01
Daily Drinker-vs-Social Drinker
6.967400E-01
Weekly Drinker-vs-Occasional Drinker
2.779700E-02
Weekly Drinker-vs-Social Drinker
3.849000E-01
Occasional Drinker-vs-Social Drinker
5.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.114300E-02
Normal-vs-Grade 2
4.304300E-03
Normal-vs-Grade 3
1.056380E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.333590E-01
Grade 1-vs-Grade 3
2.690400E-01
Grade 1-vs-Grade 4
8.114300E-02
Grade 2-vs-Grade 3
4.663200E-01
Grade 2-vs-Grade 4
4.304300E-03
Grade 3-vs-Grade 4
1.056380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.224610E-01
Normal-vs-NonDiabetic
3.688200E-01
Diabetic-vs-NonDiabetic
2.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.189400E-01
Normal-vs-NoPancreatitis
2.654600E-01
Pancreatitis-vs-NoPancreatitis
7.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.420000E-01
Normal-vs-N1
2.123800E-01
N0-vs-N1
5.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.844800E-01
Normal-vs-TP53-NonMutant
5.566400E-01
TP53-Mutant-vs-TP53-NonMutant
7.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
